再次胸骨切开对近端主动脉修复结局的影响
该回顾性研究分析了1991至2014年间1761例近端主动脉修复病例,其中25.9%为再次胸骨切开。再次胸骨切开与术后30天死亡率14%及长期生存率降低相关,但既往主动脉修复本身并未在再次胸骨切开基础上额外增加风险。
要点
- 再次胸骨切开增加近端主动脉修复术后短期和长期死亡风险。
- 既往主动脉修复(动脉瘤或AAD)未额外增加再次胸骨切开的风险。
- 冠心病是死亡率的显著预测因子。
核心结论
- 再次胸骨切开与近端主动脉修复术后短期和长期死亡率增加相关。
- 尽管需要更广泛的修复,既往近端主动脉修复(因动脉瘤或急性A型主动脉夹层)并未在再次胸骨切开基础上额外增加风险。
研究设计与样本
- 回顾性队列研究,纳入1991至2014年间所有近端主动脉修复病例,共1761例。
- 按首次修复(非再次,n=1305)和再次胸骨切开分类,再次分为既往AAD修复(n=146)、既往近端动脉瘤修复(n=165)和既往心脏(非主动脉)胸骨切开(n=145)。
- 数据分析采用列联表和多因素回归。
主要发现
- 1761例近端主动脉修复中456例(25.9%)为再次胸骨切开。
- 主动脉再次手术(redo-AAD和redo-cardiac)患者结缔组织疾病显著更多(P < .001)。
- 就诊时AAD在主动脉再次手术中最少见,其中心脏再次手术为5%,非再次手术为31%(P < .001)。
- 再次胸骨切开术后30天死亡率为14%,中心脏再次手术死亡率最高。
- 中位随访13年,非再次手术患者长期生存率显著更高(P < .001);冠心病是死亡率的显著预测因子(P < .001)。
临床怎么用
- 近端主动脉修复术前应评估再次胸骨切开状态,以权衡短期和长期死亡风险。
- 对于既往主动脉修复患者,再次手术风险主要归因于再次胸骨切开本身而非既往主动脉修复。
- 冠心病是死亡率的显著预测因子,围术期应关注冠心病管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Proximal aortic repair (AoR) in the setting of previous sternotomy may be associated with greater risk than primary repair. Our objective was to determine whether redo sternotomy increases the risk of adverse outcomes following proximal aortic surgery. METHODS: We reviewed all proximal AoRs from 1991 to 2014. Outcomes were compared between first-time AoR (non-redo = 1305) and redo AoRs, which were further classified into 3 categories: (1) previous acute type A aortic dissection (AAD) repair (redo-AAD = 146, 8.3%); (2) previous proximal aneurysm repair (redo-aneurysm = 165, 9.4%); and (3) previous cardiac (non-aortic) sternotomy (redo-cardiac = 145, 8.2%). Data were analyzed by contingency tables and multiple regression. RESULTS: In total, 456 of 1761 (25.9%) proximal AoRs had redo sternotomy. Aortic redos (redo-AAD and redo-cardiac) had significantly more connective tissue disorders (P < .001). On presentation, AAD was least common in aortic redos followed by cardiac redos (redo-cardiac) versus non-redos (5% vs 28% vs 31%, P < .001). At reoperation, 190 underwent ascending + hemiarch (21% redo-AAD, 50% redo-aneurysm, 53% redo-cardiac), 140 total arch (64% redo-AAD, 15% redo-aneurysm, 15% redo-cardiac), 110 elephant trunk (52% redo-AAD, 12% redo-aneurysm, 11% redo-cardiac), 159 AVR (36% redo-AAD, 42% redo-aneurysm, 25% redo-cardiac), and 100 aortic root (34% redo-AAD, 22% redo-aneurysm, 10% redo-cardiac). Except for pulmonary, redo sternotomy did not increase risk of postoperative complications. Thirty-day mortality after redo sternotomy was 14%-the greatest among cardiac redos. Over a median follow-up of 13 years, non-redos had significantly greater long-term survival (P < .001). Coronary artery disease was a significant predictor of mortality (P < .001). After adjustment for coronary artery disease, cardiac redos had the greatest long-term mortality risk (hazard ratio, 1.43, P < .005). Previous AoR did not significantly add risk above redo sternotomy alone (P = .734). CONCLUSIONS: Redo sternotomy is associated with increased risk for short- and long-term mortality after proximal aortic repair. Despite need for extensive repair, previous proximal aortic (for aneurysm or AAD) repair did not add further risk above that attributable to redo sternotomy.
引用
- Sandhu HK, Tanaka A, Zaidi ST, et al. Impact of redo sternotomy on proximal aortic repair: Does previous aortic repair affect outcomes? J Thorac Cardiovasc Surg. 2019. PMID: 31300224. doi:10.1016/j.jtcvs.2019.04.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。